PanCareSurPass Project HL7 FHIR Implementation Guide
1.0.0 - release 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

## CodeSystem: PCSP Conditions at risk

Official URL: http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Version: 1.0.0
Active as of 2025-10-16 | Computable Name: CsRiskConditionPcsp

Condition at risk proposed by the PCSP algorithm

This Code system is referenced in the content logical definition of the following value sets:

- RiskCondition

This case-sensitive code system `http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp` defines the following codes:

Code | Display | Definition
1 | Subsequent thyroid cancer | Subsequent thyroid cancer
2 | Subsequent breast cancer | Subsequent breast cancer
3 | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
4 | Impaired fertility Impaired spermatogenesis | Impaired fertility Impaired spermatogenesis
5 | Testosterone deficiency | Testosterone deficiency
6 | Physical sexual dysfunction | Physical sexual dysfunction
7 | Premature ovarian insufficiency | Premature ovarian insufficiency
8 | Ear problems | Ear problems
9 | Impaired glucose metabolism and diabetes melitus | Impaired glucose metabolism and diabetes melitus
10 | Dyslipidemia | Dyslipidemia
11 | Overweight and obesity | Overweight and obesity
12 | Hypertension | Hypertension
13 | Reduced bone mineral density | Reduced bone mineral density
14 | Osteonecrosis | Osteonecrosis
15 | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
16 | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
17 | Central precocious puberty (CPP) For girls with age below 8 years | Central precocious puberty (CPP) For girls with age below 8 years
18 | Central precocious puberty (CPP) For boys with age below 9 yearss | Central precocious puberty (CPP) For boys with age below 9 yearss
19 | Thyroid function problems | Thyroid function problems
20 | Cerebrovascular problem | Cerebrovascular problem
21 | Neurocognitive problems | Neurocognitive problems
22 | Peripheral neuropathy | Peripheral neuropathy
23 | Cataract | Cataract
24 | Eye problems | Eye problems
25 | Craniofacial growth problems | Craniofacial growth problems
26 | Spine scoliosis and kyphosis | Spine scoliosis and kyphosis
27 | Lower urinary tract problems | Lower urinary tract problems
28 | Obstetric problems | Obstetric problems
29 | Dental and oral problems | Dental and oral problems
30 | Gastro-intestinal problems | Gastro-intestinal problems
31 | Arrhythmia | Arrhythmia
32 | Pulmonary problems | Pulmonary problems
33 | Renal problems (Glomerular dysfunction - Tubular dysfunction) | Renal problems (Glomerular dysfunction - Tubular dysfunction)
34 | Liver problems | Liver problems
35 | Iron overload | Iron overload
36 | Spleen problems | Spleen problems
37 | Tumor predisposition | Tumor predisposition
38 | Subsequent melanoma and non-melanoma skin cancer | Subsequent melanoma and non-melanoma skin cancer
39 | Subsequent colorectal cancer | Subsequent colorectal cancer
40 | Subsequent Oral Cancer | Subsequent Oral Cancer
41 | Subsequent acute myeloid leukaemia or myelodysplasia | Subsequent acute myeloid leukaemia or myelodysplasia
42 | Subsequent bladder cancer | Subsequent bladder cancer
43 | Subsequent Bone Cancer | Subsequent Bone Cancer
44 | Subsequent lung cancer | Subsequent lung cancer
45 | Subsequent CNS neoplasms | Subsequent CNS neoplasms
46 | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
47 | Renal problems (Tubular dysfunction) | Renal problems (Tubular dysfunction)